The US FDA is beginning a pilot program that aims to speed up the time from when a drug is first identified to beginning a first-in-human clinical trial to bring medicines to market more quickly.

Medical product sponsors can apply for a pilot program launched by the UK’s Medicines and Healthcare Regulatory products Agency (MHRA) that allows them to make certain changes to their clinical trials ...